Quit or Switch: E-cigarette Study
E-cigarettes as Harm Reduction Tools in Smokers Who Fail to Quit With Traditional Methods
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: J'Neice Payne
- Phone Number: 843-876-2291
- Email: paynejne@musc.edu
Study Contact Backup
- Name: Tracy Smith, PhD
- Phone Number: 843-792-5164
- Email: smithtra@musc.edu
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- At least 21 years old
- Smoking at least 5 cigarettes per day for 1 year
- A quit attempt using an FDA-approved pharmacotherapy in the past year that resulted in abstinence of at least 24 hours
- Intention to quit smoking within the next month
- Access to daily e-mail or a smartphone that receives text messages
Exclusion Criteria:
- use of non-cigarette tobacco products in the past 30 days
- current use of pharmacotherapy for smoking cessation
- pregnant, breastfeeding, or trying to become pregnant
- household member currently enrolled in the study
- contraindicated for NRT
- planning to move out of the area within the next 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Switch Group
Participants in the Switch group will receive a 5-week supply of e-cigarettes.
|
Participants will select a Target Switch on which they will stop smoking cigarettes and switch entirely to the e-cigarette product.
|
|
Active Comparator: Meds Group
Participants in the Meds Group will receive a 5-week supply of combination nicotine replacement therapy (transdermal nicotine patch and short-acting nicotine lozenge).
|
Participants will select a Target Quit Date on which they will stop smoking, using the patches and lozenges provided.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants Who Report Daily Use of E-cigarettes or NRT and no Cigarette Use
Time Frame: day 0 through day 35
|
daily use of e-cigarette or NRT instead of cigarettes
|
day 0 through day 35
|
|
Percentage of Participants Who Have Biochemically-confirmed Abstinence From Cigarette Smoking at Week 4
Time Frame: Week 4
|
Self reported point prevalence abstinence from cigarettes and expired carbon monoxide < 6 ppm
|
Week 4
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PRO#00118102
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.